Yield10 Bioscience Inc expected to post a loss of $2.64 a share - Earnings Preview

Yield10 Bioscience

07/05/2024 03:09

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 8
(estimated) for the period ending March 31 2024
    * The Woburn Massachusetts-based  company is expected to
report a
3,025.0% increase in revenue to $1.875 million from $60 thousand
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Yield10 Bioscience Inc
is for
a loss of $2.64 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 8.9%
in the last three months. ​
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $12.00​, above​ its last closing price
of $5.15. ​​​

This summary was machine generated May 7 at 02:09 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)